June 18, 2024 02:36 PM EDT
Pharma
Law

Te­va and US gov­ern­ment dis­cuss set­tling kick­back law­suit over Co­pax­one

Katherine Lewin

News Reporter

Te­va and the US gov­ern­ment are in talks to set­tle a law­suit against the com­pa­ny al­leg­ing a kick­back scheme for its block­buster mul­ti­ple scle­ro­sis drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times